MedTrace Logo

Evaluation of Diagnostic Criteria for Creutzfeldt Jakob Disease

NCT04944732 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-06-30

No results posted yet for this study

Summary

Clinicians know little about Creutzfeldt Jakob disease, and they are not proficient in the diagnostic criteria of Creutzfeldt Jakob disease, so it is easy to misdiagnose or delay the diagnosis. As a rare central nervous system disease, it is necessary, feasible and practical to evaluate the diagnostic criteria of Creutzfeldt Jakob disease.

Conditions

  • Creutzfeldt Jakob Disease

Interventions

DIAGNOSTIC_TEST

laboratory examination, auxiliary examination, pathological results

Personal information (sex, age), medical history of present disease, past medical history, family history, symptoms and signs, supplementary examination items (including laboratory examination, impact examination)

Sponsors & Collaborators

  • Centers for Disease Control and Prevention, China

    collaborator OTHER_GOV

  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • Li Xiaogang · Peking University Third Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-01
Primary Completion
2020-01-01
Completion
2020-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04944732 on ClinicalTrials.gov